Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mecasermin in Rett Syndrome
NCT01777542Phase 2Completed
- Sponsor
- Boston Children's Hospital
- Start
- Jan 2013
- Primary completion
- Jul 2016
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of mecasermin in Rett syndrome (RTT), sponsored by Boston Children's Hospital. Started Jan 2013; status: completed.
02
Drugs
mecasermin
03
Conditions
Rett syndrome (RTT)
Beyond the preview
Go deeper on NCT01777542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01777542.